Contacts
Ross McNaughton

Ross McNaughton

Associé

Read More
Alex Dodds

Alex Dodds

Collaborateur senior

Read More
Contacts
Ross McNaughton

Ross McNaughton

Associé

Read More
Alex Dodds

Alex Dodds

Collaborateur senior

Read More

10 février 2021

Investment round for Cambridge quantum computing company

We have advised Cambridge Innovation Capital, Amadeus Capital Partners, Parkwalk and the University of Cambridge on their participation in the $20m fundraise by innovative quantum computing company Riverlane. The investment was made as part of a round led by Draper Esprit.

Riverlane's software transforms quantum computers from experimental technology into commercial products. The company raised the funds to build Deltaflow, the operating system for quantum computers. 

Commenting on the deal, Corporate Technology Partner Ross McNaughton, said: "This deal will allow Riverlane to continue to develop its operating software and transform the way cutting edge quantum technology is commercialised. This deal underlines our strong position in the Cambridge market, working with companies and investors in the deeptech space. We look forward to watching Riverlane go from strength to strength."

Steve Brierley, Founder and CEO of Riverlane, said: "For a quantum ecosystem to thrive, we urgently need an operating system. An operating system makes quantum computers useful – it allows programs and applications to run on many different machines. Riverlane aims to make our operating system Deltaflow a global standard."

The team was led by partner Ross McNaughton and associate Alex Dodds. 

Call To Action Arrow Image

Latest insights in your inbox

Subscribe to newsletters on topics relevant to you.

Subscribe
Subscribe

Related Insights

Technologie, Médias et Communications (TMC)

Advising leading underwriting and risk analytics business, Envelop Risk, on its $130 million Series B financing

24 septembre 2021

par Ross McNaughton et Alex Dodds

Cliquer ici pour en savoir plus
Fusions et acquisitions d’entreprises et marchés financiers internationaux

Revolutionising access to biology with transformational acquisition by Nuclera

13 mai 2021

par Ross McNaughton et Adrian Toutoungi

Cliquer ici pour en savoir plus
Technologie, Médias et Communications (TMC)

Advising Oxbotica in $47 million Series B investment

15 janvier 2021

par Ross McNaughton et Matt Harrison

Cliquer ici pour en savoir plus